Epidemiology of inflammatory bowel disease in Spain. A systematic review
- PMID: 11488104
Epidemiology of inflammatory bowel disease in Spain. A systematic review
Abstract
Background and objectives: Incidence and prevalence of Inflammatory Bowel Disease (IBD) differ considerably depending on the geographical region studied. In Spain, both Ulcerative Colitis (UC) and Crohn's Disease (CD) seem to have experienced an important change in terms of incidence during the past decades. Our aim was to systematically review the experience in Spain regarding the epidemiology of IBD, in particular its incidence, its geographical differences and its evolution over time.
Methods: A bibliographical search till January 2000 was conducted in Internet using the PubMed search motor and the following descriptors or key words: "Crohn's disease", "Ulcerative colitis", "Inflammatory bowel disease", "Spain" and "Spanish". Only publications providing data on IBD incidence among Spanish patients were included. References from articles that fulfilled the selection criteria were also reviewed. The endpoints considered in the review were IBD incidence rate, its geographical differences, and its evolution over time.
Results: UC incidence reported by different studies performed in Spain ranges from 0.6 to 8 cases/10(5)/year, with a mean value of 3.8. CD incidence rates in Spain ranges from 0.4 to 5.5 cases/105/year, with a mean value of 1.9. Some studies have shown differences in IBD incidence between regions in our country. Many studies have reported an increase in IBD incidence in Spain over time, although such increase is more evident in the case of CD.
Conclusions: UC incidence in Spain ranges from 0.6 to 8 cases/105/year, with a mean value of 3.8. CD figures range from 0.4 to 5.5 cases/105/year, with an average rate of 1.9. IBD incidence seems to be relatively different depending on the geographical region studied. Finally, several authors have demonstrated an increase in IBD incidence in Spain over time, although such increase seems to be more evident in the case of CD. Consequently, IBD in Spain is no longer considered a rare disease, but a relatively frequent one.
Comment in
-
[Epidemiology of intestinal inflammatory disease in a health area of the La Mancha-Centro general hospital].Rev Esp Enferm Dig. 2001 Jul;93(7):481. Rev Esp Enferm Dig. 2001. PMID: 11685944 Spanish. No abstract available.
Similar articles
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000279. doi: 10.1002/14651858.CD000279.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2017 Sep 18;9:CD000279. doi: 10.1002/14651858.CD000279.pub4. PMID: 16625534 Updated.
-
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.Cochrane Database Syst Rev. 2004;(2):CD000279. doi: 10.1002/14651858.CD000279.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000279. doi: 10.1002/14651858.CD000279.pub3. PMID: 15106148 Updated.
-
Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.Adv Ther. 2023 May;40(5):1975-2014. doi: 10.1007/s12325-023-02473-6. Epub 2023 Mar 16. Adv Ther. 2023. PMID: 36928496 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
Cited by
-
Time Trends of Crohn's Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery.J Clin Med. 2020 Sep 8;9(9):2896. doi: 10.3390/jcm9092896. J Clin Med. 2020. PMID: 32911630 Free PMC article.
-
Efficacy and safety of adalimumab for the Crohn's disease: a systematic review and meta-analysis of published randomized placebo-controlled trials.Eur J Clin Pharmacol. 2014 Aug;70(8):907-14. doi: 10.1007/s00228-014-1702-1. Epub 2014 Jun 1. Eur J Clin Pharmacol. 2014. PMID: 24880961
-
Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).Drugs Context. 2018 Mar 6;7:212505. doi: 10.7573/dic.212505. eCollection 2018. Drugs Context. 2018. PMID: 29535792 Free PMC article.
-
Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996-2001.Ir J Med Sci. 2005 Oct-Dec;174(4):28-32. doi: 10.1007/BF03168978. Ir J Med Sci. 2005. PMID: 16445157
Publication types
MeSH terms
LinkOut - more resources
Miscellaneous